Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 88.91B | 91.21B | 93.72B | 132.51B | 76.58B | 43.99B |
Gross Profit | 11.09B | 20.25B | 12.40B | 22.78B | 13.96B | 3.13B |
EBITDA | 21.20B | 16.82B | 17.76B | 28.52B | 19.86B | 3.60B |
Net Income | 2.60B | 2.62B | 4.77B | 13.89B | 5.82B | -8.63B |
Balance Sheet | ||||||
Total Assets | 144.46B | 146.95B | 142.61B | 152.17B | 137.76B | 109.65B |
Cash, Cash Equivalents and Short-Term Investments | 16.75B | 14.98B | 16.98B | 19.91B | 18.86B | 15.17B |
Total Debt | 35.80B | 34.97B | 33.11B | 31.87B | 33.13B | 31.70B |
Total Liabilities | 87.19B | 91.26B | 88.96B | 96.94B | 93.25B | 72.16B |
Stockholders Equity | 53.55B | 52.83B | 53.18B | 54.76B | 44.44B | 37.41B |
Cash Flow | ||||||
Free Cash Flow | 5.33B | 5.09B | 5.90B | 5.04B | 7.63B | 190.00M |
Operating Cash Flow | 13.57B | 13.09B | 15.12B | 5.82B | 12.86B | 4.82B |
Investing Cash Flow | -8.47B | -9.82B | -9.37B | -3.71B | -12.02B | -4.59B |
Financing Cash Flow | -4.74B | -5.38B | -5.67B | -1.09B | -2.04B | 3.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $140.30B | 10.29 | 11.75% | 4.53% | -9.86% | -32.59% | |
76 Outperform | $210.61B | 14.08 | 7.40% | 3.96% | ― | ― | |
75 Outperform | $79.74B | 9.93 | 11.25% | 25.78% | -10.84% | -61.73% | |
73 Outperform | $50.13B | 18.38 | 4.78% | 3.38% | -2.17% | -25.00% | |
73 Outperform | $64.49B | 8.09 | 18.28% | 5.71% | 3.96% | -1.69% | |
65 Neutral | $80.49B | 186.20 | -1.87% | 6.14% | -7.70% | -113.83% | |
57 Neutral | HK$84.34B | 3.62 | -2.08% | 4.89% | -4.66% | -42.32% |